Latest news
New heart drug targeting inflammation falls short in clinical trial - Cardiovascular BusinessCardiovascular Business · Thu, 06 Aug 2026 20:22:24 GMTNovo Nordisk raises forecast: shares still fell - BiostockBiostock · Wed, 05 Aug 2026 20:12:20 GMTNovo Nordisk Stock Falls 4% Despite Stronger GLP-1 Outlook - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 18:30:23 GMTNovo Nordisk Shares Likely to Fall at Open, But Less Than in U.S. Session -- Market Talk - MoomooMoomoo · Wed, 05 Aug 2026 12:29:00 GMTNovo Nordisk CEO defends economics of Wegovy pill as lower prices weigh on sales; shares fall 5% - CNBCCNBC · Wed, 05 Aug 2026 06:11:31 GMTNovo Nordisk (NVO) Releases Q2 2026 Earnings: Revenue Down 1.3%, EPS Falls 23.2% - Quiver QuantitativeQuiver Quantitative · Tue, 04 Aug 2026 21:54:00 GMTNovo Nordisk AS (NVO) Shares Fall 6.0% -- What GF Score of 75 Te - GuruFocusGuruFocus · Tue, 04 Aug 2026 21:33:45 GMTNovo Nordisk shares fall 5% after cautious 2026 sales and profit outlook despite strong Wegovy sales - PluangPluang · Tue, 04 Aug 2026 18:13:50 GMT